XML 20 R8.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2021     186.2            
Balance at beginning of period at Dec. 31, 2021 $ 3,682.9 $ (44.7) $ 1.9 $ 3,051.6 $ (57.1) $ 682.2 $ 12.4 $ (27.3) $ (25.5)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2021                 (1.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Acquisition of treasury stock (in shares)                 (1.5)
Acquisition of treasury stock (34.2)               $ (34.2)
Compensatory awards released from restriction (in shares)                 1.0
Compensatory awards released from restriction 0.0     (24.0)         $ 24.0
Share-based compensation 13.8     13.8          
Equity adjustment from foreign currency translation (13.4)             (13.4)  
Change in fair value of derivative instruments, net of tax 9.4             9.4  
Net income 86.7         86.7      
Balance at end of period (in shares) at Mar. 31, 2022     186.2            
Balance at end of period at Mar. 31, 2022 3,700.5   $ 1.9 2,984.3   781.3   (31.3) $ (35.7)
Treasury stock, balance at end of period (in shares) at Mar. 31, 2022                 (1.5)
Balance at beginning of period (in shares) at Dec. 31, 2022     186.2            
Balance at beginning of period at Dec. 31, 2022 $ 3,774.3   $ 1.9 3,012.7   852.5   (61.5) $ (31.3)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2022 (1.3)               (1.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Acquisition of treasury stock (in shares)                 (0.4)
Acquisition of treasury stock $ (9.2)               $ (9.2)
Exercise of stock options (in shares)                 0.2
Exercise of stock options 3.6     (1.2)         $ 4.8
Compensatory awards released from restriction (in shares)                 0.9
Compensatory awards released from restriction 0.0     (21.3)         $ 21.3
Share-based compensation 12.4     12.4          
Equity adjustment from foreign currency translation 5.3             5.3  
Change in fair value of derivative instruments, net of tax (0.3)             (0.3)  
Net income 25.0         25.0      
Balance at end of period (in shares) at Mar. 31, 2023     186.2            
Balance at end of period at Mar. 31, 2023 $ 3,811.1   $ 1.9 $ 3,002.6   $ 877.5   $ (56.5) $ (14.4)
Treasury stock, balance at end of period (in shares) at Mar. 31, 2023 (0.6)               (0.6)